From April 1, 2024 to April 30, 2024, the company has repurchased 4,209,500 shares, representing 0.41% for CNY 18.53 million. With this, the company has completed the repurchase of 22,174,904 shares, representing 2.16% for CNY 102.76 million under the buyback announced on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.82 CNY | +0.53% |
|
-2.55% | -43.41% |
05-20 | Shanxi Zhendong Pharmaceutical Co.,Ltd Approves Board Appointments | CI |
05-06 | Tranche Update on Shanxi Zhendong Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on February 6, 2024. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.41% | 540M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- 300158 Stock
- News Shanxi Zhendong Pharmaceutical Co.,Ltd
- Tranche Update on Shanxi Zhendong Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on February 6, 2024.